批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/06/11 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/01/31 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/04/21 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/11/18 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/08/14 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2015/01/20 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/11/30 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2010/10/29 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE 剂型/给药途径:CAPSULE;ORAL 规格:20MG;10MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021879 |
001 |
NDA |
NUEDEXTA |
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
CAPSULE;ORAL |
20MG;10MG |
Prescription |
Yes |
Yes |
AB |
2010/10/29
|
AVANIR PHARMS |
202934 |
001 |
ANDA |
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE |
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
CAPSULE;ORAL |
20MG;10MG |
Prescription |
No |
No |
AB |
2017/10/10
|
ACTAVIS ELIZABETH |
218426 |
001 |
ANDA |
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE |
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
CAPSULE;ORAL |
20MG;10MG |
Prescription |
No |
No |
AB |
2024/08/28
|
HETERO LABS LTD III |